Can we finally exonerate methotrexate as a factor in causing or exacerbating fibrotic interstitial lung disease in patients with rheumatoid arthritis?
Puja Mehta, Gabrielle Redhead, Arjun Nair, Jeffrey A. Sparks, Joanna C. Porter
Topics & Concepts
MedicineRheumatoid arthritisMethotrexateRheumatologyInterstitial lung diseaseInternal medicineDiseaseRheumatoid factorLungArthritisLung fibrosisOncologyPulmonary fibrosisInterstitial Lung Diseases and Idiopathic Pulmonary FibrosisSarcoidosis and Beryllium Toxicity ResearchRheumatoid Arthritis Research and Therapies